Interclean Shanghai

Roche Pharma India launches new mobile app for patient support

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Roche Pharma India  launched a new mobile app, The Blue Tree 2.0, for patients who are part of Roche’s Blue Tree patient support programme in India.

“The app aims to improve both the patient and healthcare professional’s experience by speeding up programme enrollment, providing easy access and advance notifications to avail multiple support services,” the company said in a statement.

Roche said the mobile app will increase the scale and reach of the programme to patients, particularly to those who are in remote locations, and will allow the support programme journey to be managed directly from their phones.

Through the Blue Tree programme patients can enroll for the programme, place request for free drug assistance, ensure doorstep delivery services of drugs and also allow advance notifications to patients on their upcoming infusion schedules.

Commenting on the launch, V Simpson Emmanuel, managing director and CEO, Roche Pharma India, said, “The launch of the app signals Roche’s goal to leverage digital platforms and mobile applications that put effective and scalable solutions, including patient support programmes at patients’ fingertips.”

To make the treatment journey a truly integrated experience for patients, Roche has partnered with Tata 1MG that overall manages The Blue Tree program and the last mile deliveries are managed by Vardhaman and IMS.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »